[HTML][HTML] Vaccine development for emerging infectious diseases
JL Excler, M Saville, S Berkley, JH Kim - Nature medicine, 2021 - nature.com
Examination of the vaccine strategies and technical platforms used for the COVID-19
pandemic in the context of those used for previous emerging and reemerging infectious …
pandemic in the context of those used for previous emerging and reemerging infectious …
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
A novel coronavirus, which has been designated as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
Dengue virus: epidemiology, biology, and disease aetiology
SK Roy, S Bhattacharjee - Canadian journal of microbiology, 2021 - cdnsciencepub.com
Dengue is a vector-borne viral disease caused by the flavivirus dengue virus (DENV).
Approximately 400 million cases and 22 000 deaths occur due to dengue worldwide each …
Approximately 400 million cases and 22 000 deaths occur due to dengue worldwide each …
Is new dengue vaccine efficacy data a relief or cause for concern?
SJ Thomas - npj Vaccines, 2023 - nature.com
Dengue is a major global public health problem requiring a safe and efficacious vaccine as
the foundation of a comprehensive countermeasure strategy. Despite decades of attempts …
the foundation of a comprehensive countermeasure strategy. Despite decades of attempts …
Prospects for a safe COVID-19 vaccine
BF Haynes, L Corey, P Fernandes, PB Gilbert… - Science translational …, 2020 - science.org
Rapid development of an efficacious vaccine against the viral pathogen severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of the coronavirus disease …
respiratory syndrome coronavirus-2 (SARS-CoV-2), the cause of the coronavirus disease …
Vaccines for COVID-19
JS Tregoning, ES Brown… - Clinical & …, 2020 - academic.oup.com
Since the emergence of COVID-19, caused by the SARS-CoV-2 virus at the end of 2019,
there has been an explosion of vaccine development. By 24 September 2020, a staggering …
there has been an explosion of vaccine development. By 24 September 2020, a staggering …
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Antibody-dependent enhancement (ADE) of disease is a general concern for the
development of vaccines and antibody therapies because the mechanisms that underlie …
development of vaccines and antibody therapies because the mechanisms that underlie …
Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases
RM Meganck, RS Baric - Nature medicine, 2021 - nature.com
The twenty-first century has already recorded more than ten major epidemic or pandemic
virus emergence events, including the ongoing and devastating coronavirus disease 2019 …
virus emergence events, including the ongoing and devastating coronavirus disease 2019 …
[HTML][HTML] COVID-19 vaccines: Current status and implication for use in Indonesia
Abstract The coronavirus disease 2019 (COVID-19) has inflicted catastrophic damages in
public health, economic and social stability—putting life globally on hold in 2020 and …
public health, economic and social stability—putting life globally on hold in 2020 and …
[HTML][HTML] Dengue virus infection–a review of pathogenesis, vaccines, diagnosis and therapy
The transmission of dengue virus (DENV) from an infected Aedes mosquito to a human,
causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar …
causes illness ranging from mild dengue fever to fatal dengue shock syndrome. The similar …